Worse pain-related physical function, psychosocial functioning, increased health care utilization reported for chronic migraine with overlapping pain
TUESDAY, Aug. 10, 2021 (HealthDay News) — Patients with chronic migraine (CM) and overlapping pain have worse pain-related physical function and psychosocial functioning than those with localized CM, according to a study recently published in Headache.
Meredith J. Barad, M.D., from the Stanford University School of Medicine in Palo Alto, California, and colleagues extracted data from the Collaborative Health Outcomes Information Registry to characterize differences in physical and psychosocial functioning in patients with CM and those with CM and co-occurring pain conditions. The number of noncephalic areas of pain endorsed on a body map was used for 1,601 patients with CM to examine the differences in pain and physical and psychosocial function.
The researchers found that across all domains, patients endorsing more body map regions reported significantly worse symptoms and functions. Endorsement of one additional body map region correlated with a 0.69-point and 1.15-point increase in pain interference and fatigue, respectively, and a 1.21-point decrease in physical function. Approximately 5 percent more physician visits were reported by patients with more widespread pain and 22 percent more body map regions were endorsed by patients reporting adverse life events prior to age 17 years.
“Overall, this study confirms in a clinical setting what has been demonstrated in large data sets; that within CM there is a distinct subpopulation of CM plus widespread pain,” the authors write.
One author disclosed financial ties to the pharmaceutical industry; a second author disclosed ties to TribeRx, which supports people with chronic pain.
Abstract/Full Text (subscription or payment may be required)
Intrauterine Instillation of Mepivacaine Reduces Pain of IUD Placement
Spinal Cord Stimulation Cuts Pain, Improves Sensation With Diabetic Nerve Damage
People Using Illicitly Sourced Fentanyl Face Worse Outcomes Than Medically Sourced Users
Updated Recommendations Address Medications to Prevent Migraine in Adults
Study IDs Risk Factors for Ketoacidosis in Adults With T2D Receiving SGLT2 Inhibitors
Therapies Compared for Newly Diagnosed Multiple Sclerosis
Initial Rx Length Tied to Long-Term Use of Z-Drugs
Paternal Exposure to Valproate Not Linked to Offspring Neurodevelopmental Disorders